Category: PSYCH STOCK NEWS

Featured

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

Editor | Curator - April 16, 2026

TESTIMONIALS

$400 Million Man Tries Psychedelic Toads.

Editor | Curator - March 24, 2026

Featured

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Editor | Curator - June 24, 2025

How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham (Stockhead)

INTERVIEW Editor | Curator - April 28, 2021

Incannex provides investors the best of breed for medicinal cannabis and psychedelic therapy development – and they’re looking at an excursion to the USA For Incannex Healthcare (ASX:IHL) CEO...

View Post

Interview: Matt Stang, CEO of Delic (DELCF). Wall Street Reporter

CLINICS Editor | Curator - February 26, 2021

#delcf, #DELIC $delcf

View Post

1...8 910Page 10 of 10

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

Featured Editor | Curator - April 16, 2026

500mg Iboga Total Alkaloid (TA) Extract. Someone posted this photo on LinkedIn, which we took as a tease....

$400 Million Man Tries Psychedelic Toads.

TESTIMONIALS Editor | Curator - March 24, 2026

"This was the most profound experience of my life. I am stunned beyond comprehension. This molecule is without peer."

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Featured Editor | Curator - June 24, 2025

The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...